Scioto Biosciences

company

About

Scioto is a developer of Activated Bacterial Therapeutics platform.

  • 51 - 100

Details

Last Funding Type
Grant
Last Funding Money Raised
$330K
Industries
Biotechnology,Diabetes,Health Care,Life Science,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
51 - 100
Operating Status
Active

Scioto Biosciences is a developer of Activated Bacterial Therapeutics (ABT) platform intended to deliver live bacteria to the gut. The company is developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics, enabling medical practitioners to advance healing through microbiome therapeutics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$2.63M
Scioto Biosciences has raised a total of $2.63M in funding over 2 rounds. Their latest funding was raised on Aug 22, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 22, 2019 Grant $2.30M 1 National Institutes of Health Detail
May 1, 2017 Grant $330K 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Scioto Biosciences is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant